Thermalin Diabetes, LLC
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Thermalin Diabetes, LLC chose not to state its revenue in its newest notice of a funding round (Jul 2014).
SEC Form D · Jul 2014
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2014
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Thermalin Diabetes, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Bruce H. Frank | Dr, Frank is the Vice President of Development. | Jul 2014 |
| Michael Weiss | Dr. Weiss is the founder and chief scientific officer of the Issuer | Jul 2014 |
| Richard Berenson | Mr. Berenson is a founder and the Chief Executive Officer of the Issuer. | Jul 2014 |
| Mitchell Briskin | Mr. Briskin is the Vice President of Strategic Relationships. | Sep 2013 |
| Gerald Wisler | Director | Jul 2014 |
| Jeffrey Elton | Director | Jul 2014 |
| John Brooks | Director | Jul 2014 |
| Michael Weiss | Dr. Weiss is the founder and chief scientific officer of the Issuer | Jul 2014 |
| Raymond Rackley | Director | Jul 2014 |
| Richard Berenson | Mr. Berenson is a founder and the Chief Executive Officer of the Issuer. | Jul 2014 |
| Joseph Jankowski | Director | Sep 2013 |
| Steven Tregay | Director | Sep 2013 |
| Michael Weiss | Dr. Weiss is the founder and chief scientific officer of the Issuer | Jul 2014 |
| Richard Berenson | Mr. Berenson is a founder and the Chief Executive Officer of the Issuer. | Jul 2014 |